Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
By O. Gutiérrez, T. Isakova, E. Rhee, Anand Shah, Julie Holmes, G. Collerone, H. Jüppner, M. Wolf. Journal of the American Society of Nephrology, 2005
908 citations recorded by the source corpus.
Subfields: Genetics, Nephrology, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/adae9cbac4674f0196e4c42334a3a0b0ac2d5d02
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
Citations in the corpus
- FGF23, PTH and Phosphorus Metabolism in the Chronic Renal Insufficiency Cohort (2011, background): “However, serum phosphate levels are normal in the vast majority of patients with early and intermediate stages of CKD due to compensatory increases in FGF23 and PTH.(5,8) o r i g i n a l a r t i c l e http://www.”